BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 21676554)

  • 1. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
    Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.
    Sorbe BG; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Gynecol Cancer; 2012 Sep; 22(7):1281-8. PubMed ID: 22864336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
    Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
    Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.
    Creutzberg CL; Nout RA; Lybeert ML; Wárlám-Rodenhuis CC; Jobsen JJ; Mens JW; Lutgens LC; Pras E; van de Poll-Franse LV; van Putten WL;
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e631-8. PubMed ID: 21640520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
    McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
    Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.